Table 1.
Baseline characteristics of non-DM patients stratified according to admission glucose
| AG ≤ 140 mg/dL M (P25, P75) N = 1216 |
140 mg/dL<AG<180 mg/dL M (P25, P75) N = 370 |
AG ≥ 180 mg/dL M (P25, P75) N = 112 |
P | |
|---|---|---|---|---|
| Age (years) | 63 (55, 76) | 64 (57, 76) | 66 (57, 73) | 0.022 |
| SBP (mmHg) | 127 (114, 141) | 124.00 (109.75, 138.00) | 125.5 (110.00, 143.75) | 0.008 |
| FPG (mg/dL) | 91.08 (83.16, 101.11) | 101.7 (91.26, 114.71) | 109.17 (92.88, 136.80) | <0.001 |
| AG (mg/dL) | 114.12 (103.36, 125.77) | 153.36 (146.11, 163.8) | 204.75 (190.21, 229.63) | <0.001 |
| HbA1C(%) | 5.60 (5.3, 5.8) | 5.70 (5.4, 6.0) | 5.80 (5.60, 6.20) | <0.001 |
| hs-CRP (ng/ml) | 6.77 (2.25, 15.26) | 7.47 (2.58, 15.95) | 8.93 (2.64, 21.21) | 0.201 |
| TC (mmol/L) | 4.34 (3.72, 5.08) | 4.39 (3.75, 4.99) | 4.23 (3.58, 4.81) | 0.363 |
| LDL-C (mmol/L) | 2.51 (2.02, 3.04) | 2.50 (2.06, 2.97) | 2.44 (1.93, 2.87) | 0.250 |
| Cr (mg/dL) | 0.95 (0.84, 1.09) | 1.05 (0.83, 1.08) | 0.98 (0.84, 1.20) | 0.228 |
| eGFR (ml/min·1.73m2) | 80.70 (64.52, 94.89) | 77.26 (65.51, 93.53) | 76.51 (60.17, 87.93) | 0.094 |
| log NT-proBNP | 3.16 (2.68, 3.66) | 3.27 (2.78, 3.80) | 3.33 (2.99, 3.87) | <0.001 |
| CK-MB ( ng/ml) | 32.10 (4.5, 105.16) | 59.89 ( 7.9, 165.75) | 74.90 ( 17.35, 209.25) | <0.001 |
| cTnI ( ng/ml) | 3.31 (0.53, 13.23) | 6.21 (0.56, 20.17) | 5.95 (1.18, 33.28) | <0.001 |
| MYO (ng/ml) | 101.5 (35.6, 250.94) | 150.50 (49.83, 301.36) | 175.39 (82.78, 428.25) | <0.001 |
| EF | 0.61 (0.54, 0.66) | 0.59 (0.51, 0.66) | 0.58 (0.51, 0.64) | 0.003 |
| HS (day) | 8.0 (6.0, 10.0) | 8.0 (6.0, 11.0) | 8.0 (6.0, 10.0) | 0.149 |
| Male | 930 (76.5) | 269 (72.7) | 130 (76.8) | 0.32 |
| Age over 75 | 324 (26.6) | 110 (29.7) | 25 (22.3) | 0.25 |
| EF below 0.4 | 88 (7.2) | 27 (7.3) | 7 (6.2) | 0.92 |
| STEMI | 585 (48.1) | 229 (61.9) | 75 (67.0) | <0.001 |
| PCI | 883 (72.6) | 285 (77.0) | 89 (79.5) | 0.09 |
| IMR | 14 (1.2) | 15 (4.1) | 6 (5.4) | <0.001 |
| OMI | 130 (10.7) | 43 (11.6) | 11 (9.8) | 0.82 |
| Hypertension | 7718 (59.0) | 241 (65.1) | 72 (64.3) | 0.08 |
| Dyslipidemia | 511 (42.0) | 170 (45.9) | 52 (46.4) | 0.32 |
| CKD | 55 (4.5) | 19 (5.1) | 5 (4.5) | 0.88 |
| Stroke history | 167 (13.7) | 65 (17.6) | 14 (12.5) | 0.15 |
| Current smoking | 589 (48.4) | 159 (43.0) | 48 (42.9) | 0.12 |
| Medication befor admission | ||||
| Aspirin | 134 (11) | 33 (8.9) | 16 (14.3) | 0.24 |
| CCB | 325 (26.7) | 115 (31.1) | 37 (33.0) | 0.13 |
| β-blocker | 131 (10.8) | 48 (13.0) | 13 (11.6) | 0.50 |
| ACEI | 104 (8.6) | 36 (9.7) | 9 (8.0) | 0.75 |
| ARB | 177 (14.6) | 44 (11.9) | 19 (17) | 0.29 |
| Statin | 136 (11.2) | 56 (15) | 10 (8.9) | 0.07 |
AG Admission glucose, SBP Systolic blood pressure, FPG Fasting plasma glucose, HbA1c Glycosylated hemoglobin, hs-CRP High-sensitivity C-reactive protein, TC Total cholesterol, LDL-C Low-density lipoprotein cholesterol, Cr Creatinine, eGFR estimated glomerular filtration rate, NT-proBNP N-terminal pro-brain natriuretic peptide, CK-MB Creatine kinase-MB, cTnI Cardiac troponin I, MYO Myoglobin, EF Ejection fraction, HS Hospital stay, STEMI ST-segment elevation myocardial infraction, PCI Percutaneous coronary intervention, IMR Insufficient myocardium reperfusion, OMI Old myocardial infraction, CKD Chronic Kidney Disease, CCB Calcium channel blocker, ACEI Angiotensin-converting enzyme inhibitor, ARB Angiotensin receptor blocker